We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

ICU Medical Inc (ICUI) Com Stk USD0.10

Sell:$171.13 Buy:$171.22 Change: $1.74 (1.03%)
Market closed |  Prices as at close on 12 August 2022 | Switch to live prices |
Change: $1.74 (1.03%)
Market closed |  Prices as at close on 12 August 2022 | Switch to live prices |
Change: $1.74 (1.03%)
Market closed |  Prices as at close on 12 August 2022 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

ICU Medical, Inc. (ICU) is engaged in the development, manufacturing and sale of medical products used in infusion therapy and critical care applications. The Company provides infusion systems, infusion consumables and critical care products used in hospital, alternate site and home care settings. The Company's product portfolio includes IV solutions, IV smart pumps with pain management and safety software technology, dedicated and non-dedicated IV sets and needle free connectors. Its oncology products include ChemoLock and ChemoClave. Its IV consumables include Clave IV Connector Technology, IV Sets, Peripheral IV Catheters and Disinfecting Caps. Its primary critical care products include Cogent, CardioFlo, TDQ and OptiQ, TriOx, Transpac and SafeSet. Its IV Solutions products include IV Therapy and Diluents, and Irrigation. Its Infusion System products include Infusion Pump Hardware, IV Mediation Safety Software and Professional Services. It offers blood pressure monitoring system.

Contact details

951 Calle Amanecer
United States
+1 (949) 3662183

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$4.09 billion
Shares in issue:
23.90 million
Health Care Supplies
United States
US dollar
NASDAQ Comb. Composite

Key personnel

  • Vivek Jain
    Chairman of the Board, Chief Executive Officer
  • Brian Bonnell
    Chief Financial Officer, Treasurer
  • Christian Voigtlander
    Chief Operating Officer
  • Virginia Sanzone
    Corporate Vice President, General Counsel and Secretary
  • Daniel Woolson
    Corporate Vice President, General Manager - Infusion Systems

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.